StockNews.AI
COR
StockNews.AI
27 days

Cencora Announces Date and Time for Third Quarter Fiscal 2025 Earnings Release

1. Cencora, Inc. will release Q3 Fiscal 2025 results on August 6, 2025. 2. Conference call scheduled for 8:30 a.m. ET to discuss results. 3. Cencora is ranked #10 on Fortune 500 with over $290 billion revenue. 4. The company aims to improve lives through secure pharmaceutical deliveries. 5. Cencora leverages a 51,000+ workforce to focus on healthcare outcomes.

Earnings
+1.74%Current Return
VS
+0.79%S&P 500
$291.1707/03 07:49 AM EDTEvent Start
$296.2307/04 02:05 PM EDTLatest Updated
4m saved
Insight
Article

FAQ

Why Bullish?

Upcoming earnings announcements typically influence stock prices positively or negatively based on expectations. Given Cencora's strong standing and focus on growth, positive performance may be anticipated.

How important is it?

Earnings announcements can significantly sway investor sentiment, especially for a growth-centric company like Cencora.

Why Short Term?

Q3 results announcement tends to affect stock prices shortly before or after release. Historical data shows positive earnings often precede price upticks.

Related Companies

PFEAMGNMRKJNJ
- CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Cencora, Inc. (NYSE: COR) today announced that it plans to release its results for the Third Quarter of Fiscal 2025 on Wednesday, August 6, 2025, prior to the opening of trading on the New York Stock Exchange. The Company will host a conference call to discuss the results at 8:30 a.m. ET on August 6, 2025. Participating in the conference call will be: Robert P. Mauch, President & Chief Executive Officer James F. Cleary, Executive Vice President & Chief Financial Officer The live call will be webcast via the Company’s website at investor.cencora.com. Users are encouraged to log on to the webcast approximately 10 minutes in advance of the scheduled start time of the call. To access the call via telephone from within the United States and Canada, dial +1 (833) 470-1428. From outside the United States and Canada, dial +1 (404) 975-4839. The access code for the call will be 015103. Replays of the call will be made available via telephone and webcast. A replay of the webcast will be posted on investor.cencora.com approximately one hour after the completion of the call and will remain available for one year. The telephonic replay will also be available approximately one hour after the completion of the call and will remain available for 7 days. To access the telephonic replay from within the United States and Canada, dial +1 (866) 813-9403. From outside the United States, dial +1 (929) 458-6194. The access code for the replay is 676245. Please check the website investor.cencora.com for updates regarding the timing of the live webcasts and for replay information. About Cencora Cencora is a leading global pharmaceutical solutions organization centered on improving the lives of people and animals around the world. Cencora partners with pharmaceutical innovators across the value chain to facilitate and optimize market access to therapies. Care providers depend on Cencora for the secure, reliable delivery of pharmaceuticals, healthcare products, and solutions. Cencora’s 51,000+ worldwide team members contribute to positive health outcomes through the power of Cencora’s purpose: Cencora is united in its responsibility to create healthier futures. Cencora is ranked #10 on the Fortune 500 and #18 on the Global Fortune 500 with more than $290 billion in annual revenue. Learn more at investor.cencora.com. More News From Cencora

Related News